Pharmaceutical Biocatalysis
Fundamentals, Enzyme Inhibitors, and Enzymes in Health and Diseases
Herausgeber: Grunwald, Peter
Pharmaceutical Biocatalysis
Fundamentals, Enzyme Inhibitors, and Enzymes in Health and Diseases
Herausgeber: Grunwald, Peter
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
The relationship between biocatalysis and the different areas of pharmaceutics is discussed in volumes 4 to 6 of Pan Stanford Series on Biocatalysis. Volume 4 provides an overview of the world market of therapeutic enzymes and enzyme inhibitors.
Andere Kunden interessierten sich auch für
- Nanotoxicology244,99 €
- Freeze Drying of Pharmaceutical Products190,99 €
- Vanda Maria Falcão Es Lopes de AndradeBiomarkers of Toxic Metals203,99 €
- Biologically Active Natural Products191,99 €
- Drug Delivery Using Nanomaterials141,99 €
- Nanotechnology and Drug Delivery, Volume Two265,99 €
- Toxicology and Risk Assessment639,99 €
-
-
-
The relationship between biocatalysis and the different areas of pharmaceutics is discussed in volumes 4 to 6 of Pan Stanford Series on Biocatalysis. Volume 4 provides an overview of the world market of therapeutic enzymes and enzyme inhibitors.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd (Sales)
- Seitenzahl: 800
- Erscheinungstermin: 26. Juni 2019
- Englisch
- Abmessung: 231mm x 157mm x 43mm
- Gewicht: 1315g
- ISBN-13: 9789814800617
- ISBN-10: 9814800619
- Artikelnr.: 57043088
- Verlag: Taylor & Francis Ltd (Sales)
- Seitenzahl: 800
- Erscheinungstermin: 26. Juni 2019
- Englisch
- Abmessung: 231mm x 157mm x 43mm
- Gewicht: 1315g
- ISBN-13: 9789814800617
- ISBN-10: 9814800619
- Artikelnr.: 57043088
Peter Grunwald studied chemistry at the Universities of Saarbrücken and Hamburg, Germany. He graduated in the field of high-frequency spectroscopy and then became a staff member of the Institute of Physical Chemistry. After receiving his PhD in physical chemistry, he founded a biotechnology research group. He was appointed professor in 2001. His research interests focus on immobilized biocatalysts, kinetics of enzymes in organic solvents, and interactions between biocatalysts and heavy metal ions. Prof. Grunwald is also interested in chemical education, including curriculum development. He has authored a textbook on biochemistry and is an editorial board member of Catalysts.
Pharmaceuticals: Some General Aspects Use of Enzymes in the Downstream
Processing of Biopharmaceuticals Therapeutic Use of Carbonic Anhydrase
Inhibitors and Their Multiple Drug Interactions Fibrinolytic Enzymes for
Thrombolytic Therapy Role of Engineered Proteins as Therapeutic
Formulations Synthesis of bioactive peptides for pharmaceutical
applications Cardiovascular Disease and Oxidative Stress Enzymatic Amino
Acid Deprivation Therapies Targeting Cancer Carboxylesterase inhibitors:
Relevance for Pharmaceutical Applications Molecular Aspects of the Activity
and Inhibition of the FAD-containing Monoamine Oxidases Multifunctional
Monoamine Oxidase and Cholinesterase Inhibitors for the Treatment of
Alzheimer's Disease The Neurodegenerative Characteristics of Alzheimer's
Disease and Related Multi-Target Drug Design Studies Aldehyde Oxidases as
Enzymes in Phase I Drug Metabolism Cytochrome P450 Enzymes for the
Synthesis of Novel and Known Drugs and Drug Metabolites Cytochromes P450,
Cardiovascular Homeostasis and Disease Protein Degradation Inducers SNIPERs
and PROTACs against Oncogenic Proteins Resistance Mechanisms of Tumor Cells
Biocatalytic Nanoreactors for Medical Purposes Computer-Aided Drug Design
for the Identification of Multi-Target Directed Ligands (MTDLs) in Complex
Diseases: An Overview The Development of Improved Therapeutics through a
Glycan-'Designer' Approach On Biocatalysis as Resourceful Methodology for
Complex Syntheses: Selective Catalysis, Cascades, and Biosynthesis
Processing of Biopharmaceuticals Therapeutic Use of Carbonic Anhydrase
Inhibitors and Their Multiple Drug Interactions Fibrinolytic Enzymes for
Thrombolytic Therapy Role of Engineered Proteins as Therapeutic
Formulations Synthesis of bioactive peptides for pharmaceutical
applications Cardiovascular Disease and Oxidative Stress Enzymatic Amino
Acid Deprivation Therapies Targeting Cancer Carboxylesterase inhibitors:
Relevance for Pharmaceutical Applications Molecular Aspects of the Activity
and Inhibition of the FAD-containing Monoamine Oxidases Multifunctional
Monoamine Oxidase and Cholinesterase Inhibitors for the Treatment of
Alzheimer's Disease The Neurodegenerative Characteristics of Alzheimer's
Disease and Related Multi-Target Drug Design Studies Aldehyde Oxidases as
Enzymes in Phase I Drug Metabolism Cytochrome P450 Enzymes for the
Synthesis of Novel and Known Drugs and Drug Metabolites Cytochromes P450,
Cardiovascular Homeostasis and Disease Protein Degradation Inducers SNIPERs
and PROTACs against Oncogenic Proteins Resistance Mechanisms of Tumor Cells
Biocatalytic Nanoreactors for Medical Purposes Computer-Aided Drug Design
for the Identification of Multi-Target Directed Ligands (MTDLs) in Complex
Diseases: An Overview The Development of Improved Therapeutics through a
Glycan-'Designer' Approach On Biocatalysis as Resourceful Methodology for
Complex Syntheses: Selective Catalysis, Cascades, and Biosynthesis
Pharmaceuticals: Some General Aspects Use of Enzymes in the Downstream
Processing of Biopharmaceuticals Therapeutic Use of Carbonic Anhydrase
Inhibitors and Their Multiple Drug Interactions Fibrinolytic Enzymes for
Thrombolytic Therapy Role of Engineered Proteins as Therapeutic
Formulations Synthesis of bioactive peptides for pharmaceutical
applications Cardiovascular Disease and Oxidative Stress Enzymatic Amino
Acid Deprivation Therapies Targeting Cancer Carboxylesterase inhibitors:
Relevance for Pharmaceutical Applications Molecular Aspects of the Activity
and Inhibition of the FAD-containing Monoamine Oxidases Multifunctional
Monoamine Oxidase and Cholinesterase Inhibitors for the Treatment of
Alzheimer's Disease The Neurodegenerative Characteristics of Alzheimer's
Disease and Related Multi-Target Drug Design Studies Aldehyde Oxidases as
Enzymes in Phase I Drug Metabolism Cytochrome P450 Enzymes for the
Synthesis of Novel and Known Drugs and Drug Metabolites Cytochromes P450,
Cardiovascular Homeostasis and Disease Protein Degradation Inducers SNIPERs
and PROTACs against Oncogenic Proteins Resistance Mechanisms of Tumor Cells
Biocatalytic Nanoreactors for Medical Purposes Computer-Aided Drug Design
for the Identification of Multi-Target Directed Ligands (MTDLs) in Complex
Diseases: An Overview The Development of Improved Therapeutics through a
Glycan-'Designer' Approach On Biocatalysis as Resourceful Methodology for
Complex Syntheses: Selective Catalysis, Cascades, and Biosynthesis
Processing of Biopharmaceuticals Therapeutic Use of Carbonic Anhydrase
Inhibitors and Their Multiple Drug Interactions Fibrinolytic Enzymes for
Thrombolytic Therapy Role of Engineered Proteins as Therapeutic
Formulations Synthesis of bioactive peptides for pharmaceutical
applications Cardiovascular Disease and Oxidative Stress Enzymatic Amino
Acid Deprivation Therapies Targeting Cancer Carboxylesterase inhibitors:
Relevance for Pharmaceutical Applications Molecular Aspects of the Activity
and Inhibition of the FAD-containing Monoamine Oxidases Multifunctional
Monoamine Oxidase and Cholinesterase Inhibitors for the Treatment of
Alzheimer's Disease The Neurodegenerative Characteristics of Alzheimer's
Disease and Related Multi-Target Drug Design Studies Aldehyde Oxidases as
Enzymes in Phase I Drug Metabolism Cytochrome P450 Enzymes for the
Synthesis of Novel and Known Drugs and Drug Metabolites Cytochromes P450,
Cardiovascular Homeostasis and Disease Protein Degradation Inducers SNIPERs
and PROTACs against Oncogenic Proteins Resistance Mechanisms of Tumor Cells
Biocatalytic Nanoreactors for Medical Purposes Computer-Aided Drug Design
for the Identification of Multi-Target Directed Ligands (MTDLs) in Complex
Diseases: An Overview The Development of Improved Therapeutics through a
Glycan-'Designer' Approach On Biocatalysis as Resourceful Methodology for
Complex Syntheses: Selective Catalysis, Cascades, and Biosynthesis